LongeVC is an international venture capital firm specializing in visionary biotech investments. With a focus on seed and early-stage funding, our mission is to bring groundbreaking biotech innovations to market, ultimately transforming the nature of our health and changing lives. Our portfolio companies span a wide range of sectors, including AI, pet health, aging medicine, and more.

These companies are at the forefront of deploying AI for personalized cancer treatments, pioneering epigenetic reprogramming, and saving lives with early ovarian cancer diagnosis. What sets LongeVC apart is our commitment to thoroughly vetting all investments to ensure impact, growth potential, and success. Our portfolio companies boast lean operational structures, rapid scaling plans, publications in peer-reviewed journals, experienced talent, and proof of concept.

When we invest in a company, we go beyond funding. We curate an ecosystem of biotech and longevity-focused companies, connecting them with a network of experienced visionaries and opportunities ready to make progress. Our two-track acceleration program supports founders and pre-seed startups, offering access to capital, expert advising, and curated relationship-building with key industry stakeholders.

Join LongeVC today to be a part of the ageless future of biotech